Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Share Option Grant

10 Sep 2015 07:00

RNS Number : 6059Y
Creightons PLC
10 September 2015
Β 

Creightons Plc

(the "Company")

Share Option Grant

This notification is made in accordance with DTR 3.1.4R(1)(a).

Creightons plc announces that the Directors of the Company listed below were granted options over shares of the Company under the Company's 2014 Share Option Plan as part of the Company's policy of providing long-term share-linked and effectively tax-free incentives to senior managers and directors. The options are for the acquisition of the following numbers of ordinary shares of 1p each in the Company:

Executive Director Number of Options

Mr BM Johnson 1,300,000

Mr M Stevens 400,000

Ms P Clark 400,000

Mr P Forster 500,000

The options were issued at 4.50p per ordinary share and can be exercised between the third and tenth anniversary of the 9th September 2015, subject to the option holder's continued employment. No consideration is payable in respect of the grant of these options.

These options have been granted to replace those granted on 28th November 2014 with an exercise price of 5.50p. These were found to have failed to qualify for registration under the Government's EMI scheme for tax relief so were surrendered by the holders and cancelled.

Β 

The board has revised the rules of the share options scheme to permit the issue of options at a discount. This has enabled the exercise price to be set so that the option holders are in the same net position as was originally intended, taking account of their income tax liability on exercise of the options on the difference between exercise price and market price on the day of grant of 6.875p.

Β 

Shareholders will benefit from this revised grant since it re-enforces the Company's policy of providing long-term share-linked and effectively tax-free incentives to senior managers.

Β 

Enquiries:

Creightons plc

Β 

NDJ O'Shea, Director

01733 281 000

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCPKCDQABKDNCK
Date   Source Headline
29th Oct 20213:53 pmRNSDirector/PDMR Shareholding
28th Oct 202111:24 amRNSDirector/PDMR Shareholding
22nd Oct 20217:00 amRNSDirector/PDMR Shareholding, Total Voting Rights
21st Oct 20217:00 amRNSDirector/PDMR Shareholding
5th Oct 20213:57 pmRNSDirector/PDMR Shareholding
5th Oct 20213:51 pmRNSDirector/PDMR Shareholding
4th Oct 20219:12 amRNSTotal Voting Rights
30th Sep 20216:29 pmRNSListing Application
27th Sep 20217:00 amRNSAcquisition of Brodie and Stone
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20217:00 amRNSBlock listing Interim Review
3rd Sep 20219:30 amRNSTotal Voting Rights
26th Aug 202111:19 amRNSFinal Dividend Declaration
25th Aug 20211:34 pmRNSResults of AGM, Final Dividend Declaration
4th Aug 20211:47 pmRNSEmma Hardie Ltd - Q&A video available
29th Jul 20217:00 amRNSAcquisition of Emma Hardie Limited and TVR
21st Jul 20212:05 pmRNSSecond Price Monitoring Extn
21st Jul 20212:00 pmRNSPrice Monitoring Extension
21st Jul 202111:05 amRNSSecond Price Monitoring Extn
21st Jul 202111:00 amRNSPrice Monitoring Extension
21st Jul 20219:05 amRNSSecond Price Monitoring Extn
21st Jul 20219:00 amRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSPreliminary Results - for year ended 31 March 2021
20th Jul 20214:17 pmRNSNotice of Results and Presentation
6th Jul 20213:24 pmRNSUpdate on Notice of Final Results
24th Jun 20217:00 amRNSPresentation on Final Results
26th Mar 202111:35 amRNSChange of Director's Role
18th Mar 20217:00 amRNSBlock Listing Six Monthly Review
16th Mar 202111:42 amRNSShare Option Grant
9th Mar 20219:52 amRNSDirector/PDMR Shareholding
25th Feb 20212:54 pmRNSDirector/PDMR Shareholding
24th Feb 20215:28 pmRNSFurther Statement regarding Innovaderma
24th Feb 20214:46 pmRNSForm 8.3 - Creightons PLC
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 20218:43 amRNSForm 8 (OPD) Creightons plc
5th Feb 20215:15 pmRNSForm 8.3 - Creightons plc
4th Feb 20216:28 pmRNSRule 2.9 Announcement
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
3rd Feb 202112:14 pmGNWForm 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 20217:00 amRNSStatement regarding Innovaderma plc
9th Dec 20207:00 amRNSHalf-year Report
24th Nov 20209:28 amRNSChange of Auditor
24th Nov 20209:19 amRNSInterim Results Presentation
30th Sep 20205:39 pmRNSResult of AGM
18th Sep 202011:37 amRNSBlock listing Interim Review
16th Sep 202011:49 amRNSHolding(s) in Company
8th Sep 20205:47 pmRNSDirector/PDMR Shareholding
8th Sep 20204:50 pmRNSReport and Accounts, AGM and Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.